Neuralstem, Inc. (CUR) financial statements (2021 and earlier)

Company profile

Business Address 20271 GOLDENROD LANE
GERMANTOWN, MD 20876
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments5724667
Cash and cash equivalents5724667
Receivables0000000
Prepaid expense1100010
Total current assets:6835778
Noncurrent Assets
Operating lease, right-of-use asset00  
Property, plant and equipment0000000
Long-term investments and receivables    000
Due from related parties    000
Intangible assets, net (including goodwill)1111111
Intangible assets, net (excluding goodwill)1111111
Other noncurrent assets  00000
Other undisclosed noncurrent assets00     
Total noncurrent assets:1111111
TOTAL ASSETS:7945889
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities0      
Employee-related liabilities0      
Debt 0     
Other liabilities  00000
Other undisclosed current liabilities1211111
Total current liabilities:1211111
Noncurrent Liabilities
Long-term debt and lease obligation00     
Operating lease, liability00  
Liabilities, other than long-term debt, including:0001100
Derivative instruments and hedges, liabilities0001122
Other undisclosed liabilities, other than long-term debt     (2)(2)
Other undisclosed noncurrent liabilities     22
Total noncurrent liabilities:0001122
Total liabilities:1222233
Stockholders' equity
Stockholders' equity attributable to parent5723646
Preferred stock0000000
Common stock0000000
Additional paid in capital227227220220219218217
Accumulated other comprehensive income (loss)(0)(0)(0)(0)(0)00
Accumulated deficit(222)(220)(218)(217)(214)(213)(211)
Total stockholders' equity:5723646
TOTAL LIABILITIES AND EQUITY:7945889

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Sublease income   0
Gross profit: 000000
Operating expenses(2)(2)(2)(2)(2)(2)(2)
Other undisclosed operating income (loss)0  (0)   
Operating loss:(2)(2)(2)(2)(2)(2)(2)
Nonoperating income (expense)000(1)101
Other nonoperating income (expense) 00(0)   
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Net loss:(2)(2)(1)(3)(0)(2)(1)
Other undisclosed net income attributable to parent0000000
Net loss available to common stockholders, diluted:(2)(2)(1)(3)(0)(2)(1)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(2)(2)(1)(3)(0)(2)(1)
Comprehensive loss:(2)(2)(1)(3)(0)(2)(1)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent0(0)(0)000(0)
Comprehensive loss, net of tax, attributable to parent:(2)(2)(1)(3)(0)(2)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: